Apixaban: a new player in the anticoagulant class

R Agrawal, P Jain, SN Dikshit - Current Drug Targets, 2012 - ingentaconnect.com
Apixaban (BMS-562247-01) is a compound being investigated as an anticoagulant.
Apixaban molecule is developed in a joint venture by Pfizer and Bristol-Myers Squibb …
被引用次数：22 相关文章

Apixaban: a new player in the anticoagulant class

R Agrawal, P Jain, SN Dikshit - Current drug targets, 2012 - pubmed.ncbi.nlm.nih.gov
Apixaban (BMS-562247-01) is a compound being investigated as an anticoagulant.
Apixaban molecule is developed in a joint venture by Pfizer and Bristol-Myers Squibb …

Apixaban: a new player in the anticoagulant class.

R Agrawal, P Jain, SN Dikshit - Current Drug Targets, 2012 - europepmc.org
Apixaban (BMS-562247-01) is a compound being investigated as an anticoagulant.
Apixaban molecule is developed in a joint venture by Pfizer and Bristol-Myers Squibb …